1.29Open1.29Pre Close0 Volume507 Open Interest5.00Strike Price0.00Turnover188.63%IV3.13%PremiumDec 20, 2024Expiry Date1.17Intrinsic Value100Multiplier5DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type-0.8569Delta0.2625Gamma3.13Leverage Ratio-0.0177Theta-0.0005Rho-2.68Eff Leverage0.0010Vega
Alto Neuroscience Stock Discussion
Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology
Wednesday, 11th December at 8:03 am
– Data generated from Alto's precision psychiatry platform and clinical-stage product candidates highlighted across three poster presentations and a panel discussion –
– New preclinical data from a reverse translation study demonstrates the link between the mechanism of ALTO-300 and the EEG biomarker used for...
<- Blackrock ->
$Alto Neuroscience (ANRO.US)$
sec.gov/Archive...
#myANROanalysis
Larger Image: tradingview.com...
$Alto Neuroscience (ANRO.US)$
No comment yet